(PharmaNewsWire.Com, March 22, 2017 ) This is primarily attributed to the increasing focus on training of medical practitioners, rising healthcare costs, growing focus on patient safety, and rising demand for minimally invasive technologies.
Browse 158 market data Tables and 31 Figures spread through 224 Pages and in-depth TOC on "Healthcare/Medical Simulation Market by Product & Services (Patient Simulator, Task Trainers, Surgical Simulator, Web-based Simulation, Software, Dental Simulator, Eye Simulator), End User (Academics, Hospital, Military) - Global Forecast to 2021" <||>rnhttp://www.marketsandmarkets.com/Market-Reports/healthcare-medical-simulation-market-1156.html
In this report the global Medical Simulation Market is segmented on the basis of products and services, end users and regions. Based on products and services, the market is segmented into medical simulation anatomical models, web-based simulation, simulation software, and simulation training services. The anatomical models market accounted for the largest share of the global market in 2015 and covers patient simulators, task trainers, surgical simulators, endovascular simulators, ultrasound simulators, dental simulators, and eye simulators. The surgical simulators market is further segmented as laparoscopic surgical simulators, arthroscopic surgical simulators, cardiovascular simulators, gynecology simulators, and others. The simulation software segment is further classified into performance recording software and virtual tutors. The simulation training services are classified into vendor-based training services, custom consulting services, and educational societies’ services. Furthermore, on the basis of end users, the market is classified into academic institutions, hospitals, military organizations, and others.
Geographically, the global medical simulation market is segmented into North America, Europe, Asia-Pacific, and the Rest of the World. In 2015, North America commanded largest share of the market. Asia-Pacific and Latin America are poised to register highest growth rates in this market mainly attributed to the untapped market potential of these regions and extensive customer base due to rising base of aging population, rising prevalence of various disorders, and demand for surgeries. The market in these two regions will be driven by developing countries such as India, China, South Korea, Singapore, Brazil, and Mexico.
The global medical simulation market is fragmented, with the presence of many small companies which operate in their respective market segments. These small market players operating at regional- and local-levels are challenging the market share of the leading players in this market. In order to maintain their market shares, leading players in the market are continuously developing new technologies and upgrading their existing products to enhance their product portfolios. The increasing competition is expected to drive innovation in the market, thereby helping the industry to overcome the existing challenges in the field of medical simulation and at the same time address the compliance issues and unmet needs of the market.
Some of the prominent players in the global medical simulation market include CAE, Inc. (Canada), Laerdal Medical AS (Norway), 3D Systems, Inc. (U.S.), Simulab Corporation (U.S.), Simulaids, Inc. (U.S.), Limbs and Things, Ltd (U.K.), Kyoto Kagaku Co., Ltd (Japan), Mentice AB (Sweden), Surgical Science Sweden AB (Sweden), and Gaumard Scientific Company, Inc. (U.S.).
Target Audience:
Medical Simulation Product Manufacturers Academic Institutes Hospitals and Clinics Military Organizations Research and Development (R&D) Companies Market Research and Consulting Firms Venture Capitalists and Investors
About MarketsandMarkets MarketsandMarkets provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 5000 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets for their painpoints around revenues decisions. Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve. MarketsandMarkets’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
Contact: Mr. Rohan Markets and Markets UNIT no 802, Tower no. 7, SEZ Magarpatta city, Hadapsar Pune, Maharashtra 411013, India 1-888-600-6441 Email: sales@marketsandmarkets.com
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
